Stocks  /  NASDAQ  /  Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

Industry:   Health Care – Major Pharmaceuticals

Stock Symbol:   ALNYNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Alnylam Pharmaceuticals, Inc. is on the Cruelty Free Investing use of animals list because they test their drugs on pre-clinical animal models – mouse, rat and non-human primate.

Additional resources:

The following release cites use of “three pre-clinical animal models – mouse, rat and non-human primate”

Alnylam Presents Pre-clinical Data from Hypercholesterolemia, Liver Cancer, Ebola, and Progressive Multifocal Leukoencephalopathy (PML) Programs at RNAi Keystone Symposium.

Company Description

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Website: http://www.alnylam.com

Contact:  http://www.alnylam.com/contact; IR: investors@alnylam.com;
Scroll to Top